Condensed Consolidated Balance Sheet (USD $)	Apr. 30, 2014	Oct. 31, 2013
Current assets:
Cash		$ 5,007
Inventories	67,487	67,487
Prepaid expenses	4,284	897
Total current assets	71,771	73,391
Fixed assets, net	82,168	111,570
Total assets	153,939	184,961
Current liabilities:
Bank overdraft	4,144
Notes payable to stockholder, net of unamortized discount of $0 and $844 in 2014 and 2013, respectively	255,450	200,606
Convertible notes payable, net of unamortized discount of $26,334 and $60,050 in 2014 and 2013, respectively	113,534	89,818
Accounts payable - trade	386,162	336,372
Accounts payable to officers and directors	195,359	131,472
Accrued payroll	353,619	244,031
Derivative liability	57,811	75,557
Anti-dilution liability	4,728	23,358
Other accrued expenses	92,283	81,016
Total current liabilities	1,463,090	1,182,230
Long-term liabilities:
Redeemable convertible preferred stock, $0.01 par value; 5,200 shares authorized, issued and outstanding at April 30, 2014 and October 31, 2013, respectively	26,000	26,000
Total long-term liabilities	26,000	26,000
Total liabilities	1,489,090	1,208,230
Commitments and contingencies
Stockholders' (deficit):
Common stock, $0.01 par value; 25,000,000 shares authorized; 5,842,614 and 5,153,027 shares issued and outstanding at April 30, 2014 and October 31, 2013, respectively	58,426	51,531
Additional paid-in capital	45,769,292	45,335,031
Accumulated deficit from previous operating activities	(27,809,201)	(27,809,201)
Deficit accumulated during the development stage	(19,353,668)	(18,600,630)
Total stockholders' (deficit)	(1,335,151)	(1,023,269)
Total liabilities and stockholders' (deficit)	$ 153,939	$ 184,961